Kelly, Jared Ryan

Track

Insider profile

Performance

Overall performance
Performance over holding periods
30 days 90 days 120 days
Average return -8% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Kelly, Jared Ryan's trades of Oncolytics Biotech Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
39.78
Quantity 87,692 -19.5%
Value US$4,001,854
Transaction date
Purchase
Price
17.34
Quantity 55,208 -40.3%
Value US$4,894,943
Transaction date
Purchase
Price
259.26
Quantity 94,540 +31.3%
Value US$1,011,155
Transaction date
Purchase
Price
0.86
Quantity 23,500 +46.6%
Value US$20,280
Transaction date
Purchase
Price
1.19
Quantity 50,400
Value US$60,062
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-13 2026-03-12
B Purchase
87,692 -19.5%
39.78
US$4,001,854 		87,692 -19.5% 39.78 US$4,001,854
2026-02-13 2026-02-12
B Purchase
55,208 -40.3%
17.34
US$4,894,943 		55,208 -40.3% 17.34 US$4,894,943
2026-02-13 2026-02-11
B Purchase
94,540 +31.3%
259.26
US$1,011,155 		94,540 +31.3% 259.26 US$1,011,155
2025-08-12 2025-08-12
B Purchase
23,500 +46.6%
0.86
US$20,280 		23,500 +46.6% 0.86 US$20,280
2025-07-17 2025-07-16
B Purchase
50,400
1.19
US$60,062 		50,400 1.19 US$60,062